antiarrhythmic drugs Flashcards

1
Q

class I MOA

A

rhythm control, Na+ channel blockers, not all just block the passage of Na ions through they channel but prolong the inactivation state of the channel. these agents prolong the recovery of the channel to resting state. Membrane-stabilizing drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

class I agents primarily affect the following

A

myocytes and purkinje fibers, by binding to voltage gated sodium channels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

how is arrhythmic tissue different than normal tissue

A

has a higher rate of depolarization and spends a lot of time in the inactive and active state and is not in the resting state very much

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

when does the antiarrhythmic drug bind

A

inactive/active state, dissociates when in the resting state, AP dec with depolarization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

why is it important to take antiarrhythmic medications chronically?

A

the drug dissociates in the resting state, if the patient stops taking the RX, arrhythmias will come right back

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Class 1A

A

intermediate Tau recovery time 1-10 seconds, not most common

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Class 1B

A

rapid recovery time, Tau less than 1 second

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Class 1C

A

slow recovery time, Tau delayed and greater than 10 seconds, most commonly used, want bc it helps drug not go back to the arrhythmia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

does the drug exclusively bind to arrhythmic tissue

A

arrhythmic not exclusive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what would happen if the drug binds to normal tissue

A

irregular tracing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

possible effects of class 1C agents

A

remain bound longest, most potential to cause arrhythmias, A and B shorter time bound

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

class 2 agents

A

beta blockers, rate control, not for severe arrhythmias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

BB ____ sympathetic activity

A

decrease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

BB ____ chronotropy, dromotropy, ionotropy activity

A

decrease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

BB ____ SA nodal depolarization and AV nodal conduction

A

decrease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

when are class 2 agents used

A

SNS induced arrhythmias - heart attacks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

why are class II agents good in treating arrhythmias caused by class I (probs C) agents

A

slows down the conduction
comes off the tissue in resting
bblockers puts in rest phase for a longer period of time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

class III agents

A

rhythm, dosing is important, causes ventricular arrhythmias and sudden death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

class III moa

A

prolongs the action potential duration, mainly blocks the K+ channels (lengthens phase 3), slows/decreases depolarization, inc in action potential duration and the effective refractory period

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what type of arrhythmias does class 3 treat?

A

reentry arrhythmias, increases the ERP (effective refractory period) when the signal comes in too early with class three and the drug comes in but the tissue doesn’t respond

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

class III agents effect on EKG

A

prolongs the QT interval, T wave shifts right, stretches out your tracing, extended prolongation is called Torsades de Pointe (twisting of QRS complex happens if extended repolarization too long)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

class IV agents

A

calcium channel blockers, rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Class IV agents moa

A

dec heart rate and dec AV nodal conduction (PR interval increases), negative ionotropic (like CCB - can’t use for a pt in heart failure)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

two CCB used for arrhythmias

A

non-DHP verapamil (calan) and diltiazem (procardia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Quinidine MOA
class 1A agent, Na+ blocks, has some class III activity and blocks the K+ channels,
26
Quinidine AE
blocks the alpha 1 receptors significant anti-muscurinic activity (AE constipation, anti-slud, salavation), GI issues in 30-50% of patients (mainly diarrhea), cinchonism (headache, dizziness, ringing in ears), bblocking effects, make sure the pressure doesn't fall to much
27
Quinidine metabolism
primarily CYP3A4, inhibits CYP2D6
28
Quinidine drug interactions
reduces clearance of digoxin by 50% - digoxin needs dose adjustments 30-50%, blocks the alpha 1 receptors
29
procanimide MOA
class 1A, blocks Na+ channels but does not block the alpha 1 channels like quinidine does so it has fewer antimuscurinic effects
30
what is procanimide used for
acute care settings for ventricular arrhythmias
31
why is there a limited use of procainamide
lupus like effects (auto-immune), reversible (goes back to normal)
32
lidocaine MOA
class 1B, no non-class 1 activity
33
positive uses of lidocaine
high efficacy, low toxicity (therapeutic range is 2-6 micrograms)
34
negative uses of lidocaine
poor bioavailability (3%)
35
when is lidocaine used
acute post-MI setting for the termination of ventricular tachycardia
36
Perks of 1C agents
Long tau recovery time - pro arrhythmic activity- reserved for supraventricular arrhythmias who have no structural heart disease, 2nd or 3rd line agent, used in hospital, more likely to cause arrhythmias
37
Flecanide MOA
Class 1C agent, some class III, blocks Na+ and some K+
38
Metabolism of flecinide
2D6 substrate, dec CL in patients with hepatic & Renal insufficiency, tobacco inc hepatic metabolism
39
Flecanide AE
Non cardiac: blurred vision, dizziness, edema, abdominal pain, comstipation and headache, I’m first 2-4 weeks. May require dose adjustment Nausea / vomit - GI Mild negative chronotropic (contract) effect that exacerbated congestive heart failure
40
Propafdnone MOA
Similar to flecainide as well as week bblocking activity, B2- affects lungs, B1- no respiratory issues
41
Propafenone metabolism
Metabolized by cyp 2D6 and inhibits 2D6, cL decreased in patients with hepatic insufficiency
42
PB of propafenone
85-97% PB
43
Special considerations propafenone
Contraindications in patients with acute bronchospasms, bioavailability of rhythmol 325mg twice daily is equal to IR of propafenone 150mg PO 3x daily
44
Class 2 uses
SNS-induced arrhythmias, catecholamine induced arrhythmias (pheochrpmocytoma)
45
AE class 2 agents
Hypotension and Brady Cardiac- avoid I’m low BP, can cause heart block, avoid in bradycardia
46
Class 2 agents contraindication
Use with caution in patients with asthma/COPD and diabetes (masks signs of hypoglycemia
47
Esmolol half life
Ultra short acting - t1/2 10 mind, no titration needed bc half life is so short and there’s s short term control of the arrhythmia, IV only
48
Uses of esmolol
B1 selective so can be given to pets with respiratory issues, used in acute care setting for rapid short term control of supraventricular arrhythmia (sinus tachycardia, afib)
49
Propranolol MOA
Blocks B2 and B1, some class 1 activity
50
Propranolol admin
PO and IV
51
Class 3 agents MOA
Prolongs phase 3 by blocking K+ channels, small number of agents increase inward current of Na and Ca, K increases, good for reentry arrhythmias, blocks efflux, becomes more positive inside the cell
52
Amiodarone MOA
K+ channel blocker (3), Na+ channel blocker (1), bblocker (2), Ca+ channel blocker (4), inhibition of cell cell coupling, thyroid hormone/receptor effects (channel expression)
53
Amiodarone pharmaco kinetics
highly lipophilic, crosses everything easily, derivative of thyroid hormone
54
Amiodarone - half life
complex elimination half life. rapid component of 3-10 days, slower component of several weeks
55
implications of amiodarone
AE, 7-8 months to eliminate from the body, have to give a loading dose, agressive
56
loading dose amiodarone oral
1g/day divided doses over two weeks then 200-400mg per day
57
IV loading dose
acute treatment of ventricular arrhythmias: 150mg IV bolus followed by 1mg/min x 6hrs, then 0.5mg/min x 18hrs; followed by 200mg/day oral starting dose
58
metabolism of amiodarone
CYP 3A4, inhibits CYP 2C9 (inc warfarin), inhibits PGP (dec digoxin)
59
why would patients be on warfarin along with amiodarone?
afib puts them at risk for clots, atria is not pumping properly and the blood pools, make sure the patient doesn't have a clot before putting them on meds - put on warfarin and then put them on amiodarone - make dose adjustments
60
AE/toxicity of amiodarone
``` pulmonary fibrosis (shortness of breath) 10%, most significant type of effect thyroid dysfunction corneal diposits (most pts experience) photodermatitis (rash, sensitive to sunlight, sunscreen and layers) ```
61
donedarone uses
same benefit of amiodarone but not as many AE (iodine groups are removed, amiodarone still works so much better, dec thyroid toxicity, lipophilicity, tissue accumulation and half-life goes down
62
PB bound donedarone
98%
63
metabolism donedarone
inhibits C2D6 and 3A4
64
implications of donedrone
patients > 65 have 23% greater exposure than those <65, females have 30% greater exposure than males bioavailability inc with high fat meals
65
AE dronedrone
GI common, worsen HF, skin and soft tissue reaction (pruritis, rash, eczema, atopic dermatitis)
66
special considerations of donederone
pregnancy category X, twice daily with meals, dispense MedGuide with each prescription and refill, contraindicated in severe hepatic impairment
67
sotalol moa
class III (blocks K+), prolongs the QT interval: torsades de pointe, t wave shifts to the right, generally well tolerated
68
why sotalol and what happens if stop sotalol
generally well tolerated, fast ventricular arrhythmias if taking off sotalol
69
elimination of sotalol
eliminated mostly by the kidneys (dose adjustments), few drug interactions
70
dofetilide moa
class III agent
71
implications of dofetilide
last choice selection: patients with AF who are highly symptomatic (works well, lots of safety considerations), other AA helf for 3 half lives prior to admin
72
admin of dofetilide
admin by a cardiologist
73
elim of dofetilide
renally eliminated, contraindicated with CrCl < 20
74
contraindication dofetilide
avoid other drugs that prolong QT interval
75
ibutalide implications
prolongation of QT interval, dose dependent (give lowest dose), torsades de pointe
76
ibutalide rout of admin
extensive 1st pass metabolism
77
CCBs
class IV agents, verapamil and diltiazem
78
what are class IV agents good for
rate control, monitor reflex tachycardia and increased activation of the AV node, often with CCB
79
metabolism of class IV agents
CYP 3A4, drug interactions
80
class IV disease contraindications
HF
81
adenosine half life
10 seconds, admin 3 seconds
82
why adenosine
code situation of severe tachycardia, IV, induces but transient AV nodal block, patient may go into transient ventricular a-systole
83
digoxin moa
inhibits the Na/K ATPase, increases intracellular Ca, increases vagal activity, rate control drug, mimics PNS (parasympathomimetic), ability to decrease the AV nodal conduction (vagal like effect),
84
digoxin - why?
favored over class II and IV agents in treating patients with supra-ventricular arrhythmias who also have heart failure, + inotropic effect, has become a third line agent